Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect

Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect

Item
http://www.wikidata.org/entity/Q35127913
Clinical pharmacokinetics of oral controlled-release 5-fluorocytosineThe initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy.Antifungal pharmacokinetics and pharmacodynamicsOptimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosingAntifungal therapeutic drug monitoring: established and emerging indications.Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology.Clinical pharmacology of antifungal agents to overcome drug resistance in pediatric patients.Pharmacodynamics for antifungal drug development: an approach for acceleration, risk minimization and demonstration of causality.Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis.Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect.
P2860

Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect

Item
http://www.wikidata.org/entity/Q35127913
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Derivation of an in vivo drug ...... otype on the antifungal effect
@ast
Derivation of an in vivo drug ...... otype on the antifungal effect
@en
type
label
Derivation of an in vivo drug ...... otype on the antifungal effect
@ast
Derivation of an in vivo drug ...... otype on the antifungal effect
@en
prefLabel
Derivation of an in vivo drug ...... otype on the antifungal effect
@ast
Derivation of an in vivo drug ...... otype on the antifungal effect
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Derivation of an in vivo drug ...... otype on the antifungal effect
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932